Author Guidelines

Journal of Pharmacological Sciences and Experimental Therapeutics (NISPET Journal, ISSN XXXX XXXX) is a peer reviewed and the official Journal of the Nigerian Society for Pharmacological Sciences and Experimental Therapeutics (NISPET). The society is a scientific organization with a mission to further the growth of Pharmacology and Experimental Therapeutics in Nigeria.

 

Manuscript Submission Guidelines/Preparation

Review Article: Maximum length of manuscripts should be 6000 words (24 pages, double-spaced). Research Article: 5000 words (18 pages, double-spaced).

Technical notes, Commentaries and Short communications (Cameo): 1,500 words (6 pages, double-spaced).

 

For other types of presentations, e.g. Letters to the Editor, please contact the Editor (this should be between 300 and 800 words).

Manuscript Format

The preferred format of all manuscripts is MS Word (Font type: Times New Roman, Font size: 12). All Figures, Tables and images must be inserted in the manuscript at the position they should appear when published.

 

Manuscript Style

Manuscript should be written in English.

Each manuscript should be typed double-spaced on A4 (8.5″ × 11″) paper size with 1 inch margins. It should be arranged in the following order: Title, Abstract, Keywords (3 to 5), Introduction, Materials and Methods (Methods for Operational Research), Results, Discussion, Conclusion, Acknowledgment, Declaration of Conflict of Interest and References.

 

First page of manuscript

This should include the title of the article, names of the authors (First name, middle initial and the last name), and their affiliations. The corresponding author must provide the full corresponding address (including telephone and e-mail address) at the bottom of the page.

 

Second page of manuscript

The Abstract (no more than 300 words) should be presented on the second page along with title and keywords (4 to 6). The abstract should be structured into: Background, Objectives, Methods, Results, and Conclusion.

Introduction

An introduction should provide a background to the study (appropriate for an international audience). Related literature, based on the objectives of the study, should be indicated and clearly states the specific objectives of the study at the end of this section. Please ensure that any abbreviations and all symbols used in equations are fully defined. Approximate length is 500 - 1000 words.

 

Materials and Methods (or Methods)

This section should describe the materials and methods used in sufficient detail to allow the study to be replicated. Please include details of ethical approval in this section. Data analysis methods, including the appropriate statistical analysis performed, should be provided. Approximate length is 500 - 1000 words. Review Articles may not necessarily have a Materials and Methods section.

Results

This section should first summarize all the results in the text before referring to Tables and Figures for details. It is essential to include statistical analyses or other indicators to enable assessment of the variance of replicates of the experiments. Data should not be repeated in Figures and Tables. Approximate length is1000 - 1500 words.

Discussion

The discussion section should summarize the main findings, interpret the findings, and compare them with previous studies, as well as the contribution made to the field. Indicate unanswered questions/provide direction for future research. This should be followed by a critique of the strengths and limitations of the research, including any policy limitations. Approximate length is 1000 words.

 

Conclusions

A brief conclusion section should summarize the salient findings of the study based on the study objectives. Authors are strongly advised to emphasize their contribution to the field by their research in this section. Approximate length is 200 words.

 

Review Articles may be structured along suitable segments of the review. However, Introduction and Conclusion sections are required.

References

References should be typed single-spaced and numbered consecutively in the order in which they are cited in the text following the Vancouver style referencing format. Arabic numerals (in superscript), e.g., 1, 3, 5 or 1-4 should be used in citing references in the text.

Index Medicus Style of abbreviations should be used for Journals cited.

For correct abbreviations, visit http://www.ncbi.nlm.nih.gov/PubMed/jbrowser.html. Unpublished work should not be included in the list of references.

 

Examples

Journal Articles

  1. Kavanagh PL, Fasipe TA, Wun T. Sickle Cell Disease: A Review. JAMA. 2022;5;328(1):57-68. doi: 10.1001/jama.2022.10233
  2. Piel FB, Steinberg MH, Rees DC. Sickle Cell Disease. N Engl J Med. 2017;376(16):1561-1573. doi: 10.1056/NEJMra1510865.
  3. Adigwe OP, Onavbavba G, Onoja SO. Impact of Sickle Cell Disease on Affected Individuals in Nigeria: A Critical Review. Int J Gen Med. 2023;16:3503-3515. doi: 10.2147/IJGM.S410015.

Entire Book:

Malamed SF. Handbook of local anesthesia. 7th ed. St. Louis: Elsevier; 2020.

 

Chapter of book compiled by an editor with various chapter contributors

  1. Meheus AZ. Practical approaches in developing nations. In: Holmes KK, Mardh PA, Sparling PF, Wiesner PF, (eds). Sexually transmitted diseases. 1st ed. New York: McGraw-Hill, 1984. p. 998-1008.
  2. Forrest JL, Miller SA. Evidence-based decision making. In: Bowen DM, Pieren JA, editors. Darby and Walsh dental hygiene theory and practice. 5th ed. Maryland Heights: Elsevier; 2020. p. 25-33.

 

Online or Website References

Marchildon GP, DiMatteo L. Health care cost drivers: the facts [Internet]. Canadian Institute for Health Information; 2011 Oct [Accessed 2015 Jan 15]. Available from: https://secure.cihi.ca/free_products/health_care_cost_drivers_the_facts_en.pdf

Tables

These should be numbered with Arabic numerals. Each Table should be typed using a table format (i.e., each variable must be typed into a separate cell in the Table) with only horizontal lines above and below the table column headers and at the bottom of the Table (using 1 point for the top and bottom lines and ½ point for any middle line). No vertical lines should be included in any Table. Each Table MUST be inserted at the appropriate position in the text just below where it was referred to the first time. The title should be typed at the top of the Table in the sentence case format, i.e., only the first name should be in capital letters; names should also be in capital letters, as appropriate. Any legend should be typed at the top and bottom of the Table in italics.

Illustrations

Figures should be professionally drawn electronically and inserted in the appropriate position where it was first cited within the text. If photographs of patients are used, either the subjects are not identifiable, or their pictures must be accompanied by a written permission to use the images. Photographs must be clear and sharp. Labels of the Figure MUST be in text form at the bottom and MUST not form part of the image.

 

Copyright

It is a condition of publication that authors grant the Nigerian Society for Pharmacological Sciences and Experimental Therapeutics (NISPET) the exclusive license to publish all articles, including abstracts. Authors retain copyright of their work, which means they may re-use their work for non-commercial purposes without asking permission of the publisher. Authors are responsible for obtaining permission to reproduce copyright material from other sources.

 

Ethical Matters

Authors using experimental animals and human subjects in their investigation must seek approval from the appropriate Ethical Committee in accordance with “Guide for the Care and Use of Laboratory Animals, 8th Edition” (National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. 8thedition. Washington (DC): National Academies Press (US); 2011. Available from: https://www.ncbi.nlm.nih.gov/books/NBK54050/ doi: 10.17226/12910) and/or the Declaration of Helsinki

 

promulgated in 1964 as amended in 2024. The Methods section must include a statement to prove that the investigation was approved and that informed consent was obtained.

Ethics in Publishing

Authors must follow ethical guidelines.

 

Submission Declaration

When authors submit an article to Journal of Pharmacological Sciences and Experimental Therapeutics (NISPET Journal), it is implied that:

  • The work described has not been published previously except in the form of a preprint, an abstract, a published lecture, an academic thesis or registered report.
  • The article is not under consideration for publication elsewhere.
  • The article's publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out.
    • If accepted, the article will not be published elsewhere in the same form, in English or in any other language, including electronically, without the written consent of the copyright holder.

 

The manuscript should be submitted through the journal email: editorinchief@nispetng.org

The financial implication per scientific publication is as follows:

As a member of NISPET, you will be paying N25,000 only– attach proof of payment of 2025 Annual due. For members not currently registered in this financial year (and non-member), payment is N45,000 only. International authors are to pay $150

 

Enquiry

The Editor

Journal of Pharmacological Sciences and Experimental Therapeutics (NISPET Journal)

E-mail: editorinchief@nispetng.org maoakanmu@yahoo.com

Phone: +2348035958466